Tovet Foam

Generic name:clobetasol propionate
Dosage form: aerosol, foam
Drug class:Topical steroids

Medically reviewed by Drugs.com. Last updated on Sep 1, 2020.

Indications and Usage for Tovet Foam

Tovet Foam is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years and older.

Tovet Foam Dosage and Administration

• Apply a thin layer of Tovet Foam to the affected area(s) twice daily, morning and evening, for up to 2 consecutive weeks; therapy should be discontinued when control has been achieved.
• The maximum weekly dose should not exceed 50 g or an amount greater than 21 capfuls per week.
• For proper dispensing of foam, shake the can, hold it upside down, and depress the actuator.
• Dispense a small amount of foam (about a capful) and gently massage the medication into the affected areas (excluding the face, groin, and axillae) until the foam is absorbed.
• Tovet Foam is not for oral, ophthalmic, or intravaginal use.
• Avoid contact with the eyes.
• Avoid use on face, axillae, and groin, or if skin atrophy is present at the treatment site.
• Wash hands after each application.

Dosage Forms and Strengths

Tovet (clobetasol propionate) Foam, 0.05% (Emulsion) contains 0.5 mg of clobetasol propionate, USP per gram.

Contraindications

None.

Warnings and Precautions

Effects on Endocrine System

Clobetasol propionate foam, 0.05% (emulsion) has been shown to suppress the hypothalamic-pituitary-adrenal (HPA) axis.

Systemic absorption of clobetasol propionate foam, 0.05% (emulsion) has caused reversible HPA axis suppression with the potential for clinical glucocorticoid insufficiency. This may occur during treatment or upon withdrawal of the topical corticosteroid. Use of clobetasol propionate foam, 0.05% (emulsion) for longer than 2 weeks may suppress the immune system [see Nonclinical Toxic...